93 related articles for article (PubMed ID: 20203107)
1. Passive immunization against nicotine attenuates somatic nicotine withdrawal syndrome in the rat.
Malin DH; Moon WD; Goyarzu P; Magallanes N; Blair MB; Alexander MR; McDavid L; Spurgeon JL; Ennifar S; Fattom A
Nicotine Tob Res; 2010 Apr; 12(4):438-44. PubMed ID: 20203107
[TBL] [Abstract][Full Text] [Related]
2. Nicotine withdrawal in adolescent and adult rats.
O'Dell LE; Bruijnzeel AW; Ghozland S; Markou A; Koob GF
Ann N Y Acad Sci; 2004 Jun; 1021():167-74. PubMed ID: 15251887
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of monoamine oxidase isoforms modulates nicotine withdrawal syndrome in the rat.
Malin DH; Moon WD; Goyarzu P; Barclay E; Magallanes N; Vela AJ; Negrete AP; Mathews H; Stephens B; Mills WR
Life Sci; 2013 Oct; 93(12-14):448-53. PubMed ID: 23988853
[TBL] [Abstract][Full Text] [Related]
4. L-DOPA attenuates nicotine withdrawal-induced behaviors in rats.
Ohmura Y; Jutkiewicz EM; Domino EF
Pharmacol Biochem Behav; 2011 Jun; 98(4):552-8. PubMed ID: 21354201
[TBL] [Abstract][Full Text] [Related]
5. Passive immunization against nicotine prevents nicotine alleviation of nicotine abstinence syndrome.
Malin DH; Lake JR; Lin A; Saldaña M; Balch L; Irvin ML; Chandrasekara H; Alvarado CL; Hieda Y; Keyler DE; Pentel PR; Ennifar S; Basham LE; Naso R; Fattom A
Pharmacol Biochem Behav; 2001 Jan; 68(1):87-92. PubMed ID: 11274712
[TBL] [Abstract][Full Text] [Related]
6. Selective c-fos induction and decreased dopamine release in the central nucleus of amygdala in rats displaying a mecamylamine-precipitated nicotine withdrawal syndrome.
Panagis G; Hildebrand BE; Svensson TH; Nomikos GG
Synapse; 2000 Jan; 35(1):15-25. PubMed ID: 10579804
[TBL] [Abstract][Full Text] [Related]
7. Characterization of spontaneous and precipitated nicotine withdrawal in the mouse.
Damaj MI; Kao W; Martin BR
J Pharmacol Exp Ther; 2003 Nov; 307(2):526-34. PubMed ID: 12970387
[TBL] [Abstract][Full Text] [Related]
8. Effects of nitric oxide synthase inhibitors in attenuating nicotine withdrawal in rats.
Jain R; Mukherjee K; Mohan D
Pharmacol Biochem Behav; 2008 Feb; 88(4):473-80. PubMed ID: 18031800
[TBL] [Abstract][Full Text] [Related]
9. Differential effects of passive immunization with nicotine-specific antibodies on the acute and chronic distribution of nicotine to brain in rats.
Pentel PR; Dufek MB; Roiko SA; Lesage MG; Keyler DE
J Pharmacol Exp Ther; 2006 May; 317(2):660-6. PubMed ID: 16407464
[TBL] [Abstract][Full Text] [Related]
10. Passive immunization with a nicotine-specific monoclonal antibody decreases brain nicotine levels but does not precipitate withdrawal in nicotine-dependent rats.
Roiko SA; Harris AC; LeSage MG; Keyler DE; Pentel PR
Pharmacol Biochem Behav; 2009 Aug; 93(2):105-11. PubMed ID: 19393688
[TBL] [Abstract][Full Text] [Related]
11. Extended access to nicotine self-administration leads to dependence: Circadian measures, withdrawal measures, and extinction behavior in rats.
O'Dell LE; Chen SA; Smith RT; Specio SE; Balster RL; Paterson NE; Markou A; Zorrilla EP; Koob GF
J Pharmacol Exp Ther; 2007 Jan; 320(1):180-93. PubMed ID: 17050784
[TBL] [Abstract][Full Text] [Related]
12. Bupropion attenuates nicotine abstinence syndrome in the rat.
Malin DH; Lake JR; Smith TD; Khambati HN; Meyers-Paal RL; Montellano AL; Jennings RE; Erwin DS; Presley SE; Perales BA
Psychopharmacology (Berl); 2006 Mar; 184(3-4):494-503. PubMed ID: 16163521
[TBL] [Abstract][Full Text] [Related]
13. Blockade of nicotinic acetylcholine or dopamine D1-like receptors in the central nucleus of the amygdala or the bed nucleus of the stria terminalis does not precipitate nicotine withdrawal in nicotine-dependent rats.
Jonkman S; Markou A
Neurosci Lett; 2006 May; 400(1-2):140-5. PubMed ID: 16563623
[TBL] [Abstract][Full Text] [Related]
14. A subtype-specific neuropeptide FF receptor antagonist attenuates morphine and nicotine withdrawal syndrome in the rat.
Malin DH; Henceroth MM; Elayoubi J; Campbell JR; Anderson A; Goyarzu P; Izygon J; Madison CA; Ward CP; Burstein ES
Neurosci Lett; 2018 Sep; 684():98-103. PubMed ID: 29981879
[TBL] [Abstract][Full Text] [Related]
15. Monoamine oxidase inhibition dramatically prolongs the duration of nicotine withdrawal-induced place aversion.
Guillem K; Vouillac C; Koob GF; Cador M; Stinus L
Biol Psychiatry; 2008 Jan; 63(2):158-63. PubMed ID: 17643399
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of Rhodiola rosea L. extract on affective and physical signs of nicotine withdrawal in mice.
Mattioli L; Perfumi M
J Psychopharmacol; 2011 Mar; 25(3):402-10. PubMed ID: 19939867
[TBL] [Abstract][Full Text] [Related]
17. SU-6656, a selective Src kinase inhibitor, attenuates mecamylamine-precipitated nicotine withdrawal syndrome in mice.
Rehni AK; Singh TG; Arora S
Nicotine Tob Res; 2012 Apr; 14(4):407-14. PubMed ID: 22102627
[TBL] [Abstract][Full Text] [Related]
18. Nicotine reversal effects of the benzoflavone moiety from Passiflora incarnata Linneaus in mice.
Dhawan K; Kumar S; Sharma A
Addict Biol; 2002 Oct; 7(4):435-41. PubMed ID: 14578021
[TBL] [Abstract][Full Text] [Related]
19. Ability of baclofen to prevent somatic manifestations and neurochemical changes during nicotine withdrawal.
Varani AP; Moutinho LM; Calvo M; Balerio GN
Drug Alcohol Depend; 2011 Dec; 119(1-2):e5-12. PubMed ID: 21733642
[TBL] [Abstract][Full Text] [Related]
20. The nitric oxide synthesis inhibitor nitro-L-arginine (L-NNA) attenuates nicotine abstinence syndrome in the rat.
Malin DH; Lake JR; Shenoi M; Upchurch TP; Johnson SC; Schweinle WE; Cadle CD
Psychopharmacology (Berl); 1998 Dec; 140(3):371-7. PubMed ID: 9877017
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
